Experts discuss latest advances to improve quality of life for children with dwarfism

A forum on dwarfism was held, featuring scientific discussions on cases of skeletal dysplasia in children, highlighting its impact on society, and introducing the causes and latest available treatments. The event brought together leading consultants in genetics, endocrinology, and bone disorder specialists.

The forum aimed to raise medical awareness of skeletal dysplasias, present the latest medical developments and solutions, and emphasize their role in improving growth rates in children and reducing complications, thereby enhancing quality of life and supporting their active integration into society.

Extensive scientific sessions were held, where participants discussed the latest clinical updates, scientific standards for using advanced therapies, modern protocols for early diagnosis, systematic medical intervention, and comprehensive multidisciplinary care approaches.

Dr. Maha Faden, consultant in genetics and hereditary skeletal dysplasias at King Saud Medical City, reviewed recent medical and research developments in managing rare bone dwarfism disorders, stressing the importance of community awareness about early screening to improve patients' quality of life.

Faden noted that recent advances in biological therapies for achondroplasia stimulate the growth of long bones in children with dwarfism. She explained that these therapies work by inhibiting the cellular signaling pathway responsible for slowing or preventing normal cartilage growth, which helps limbs grow better and improves patients' skeletal structure.

Dr. Maha Faden, who contributed to establishing and developing the medical genetics unit at King Saud Medical City, called for greater early health awareness about rare genetic diseases, emphasizing the importance of encouraging families to benefit from advanced genetic testing and modern technologies. She highlighted their pivotal role in achieving rapid and accurate diagnosis and enabling timely medical intervention for maximum treatment effectiveness.

Meanwhile, Dr. Abdulhadi Habib, pediatric endocrinology consultant at Prince Mohammed bin Abdulaziz Hospital in Madinah, stressed the critical importance of early diagnosis and comprehensive psychological support, giving families the best opportunity for emotional preparation and sound treatment planning before the child's birth.

He pointed out that the recent breakthroughs in therapeutic research for this condition promise success not only in increasing height, but also in treating and alleviating associated complications and congenital deformities, especially spinal curvature and narrowing of neural canals, which can improve mobility and prevent chronic pain.

Dr. Abdulhadi Habib emphasized the need to focus on psychological and social aspects, noting that individuals with dwarfism face societal challenges such as bullying at school or in the workplace. He called for intensified psychological counseling and moral support for both patients and their families to enhance their ability to cope, build self-confidence, and achieve full and effective integration into society.

For her part, Dr. Afaf Al-Saghir, consultant in endocrinology and pediatrics at King Faisal Specialist Hospital in Riyadh, explained that "dwarfism" is not a single condition but a clinical description of severe short stature, with over 400 different medical causes.

The pediatric consultant outlined the main challenges and medical complications associated with achondroplasia, warning that some can be life-threatening. Among the most serious is narrowing of the foramen magnum at the skull base, which may compress the brainstem during infancy. Other major challenges include respiratory and motor disorders such as sleep apnea, delayed motor skills, obesity, and bone and hearing issues like recurrent ear infections, hearing loss, spinal curvature, bowed legs, and spinal canal narrowing in adulthood.

The consultant at King Faisal Specialist Hospital in Riyadh called for early diagnosis, whether during pregnancy through imaging and genetic testing, or immediately after birth. She stressed that early intervention can change a child's life trajectory for three key reasons: it allows for organized follow-up, guides parents on proper handling and seating to prevent spinal curvature, and enables monitoring of hearing and nutrition.

Dr. Afaf affirmed that the treatment landscape for dwarfism is undergoing a true transformation. After decades in which medical care focused on surgically managing complications, the field is now shifting toward addressing the root cause, as new drugs directly target the excessive signaling from the FGFR3 gene receptor.

Doctors emphasized that providing such advanced therapies marks a qualitative leap in Saudi Arabia's healthcare sector, underlining the importance of collaboration among health authorities, the media, and families to spread health awareness and support patients and their families with reliable information.